Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.67663 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.82571 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.63139 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.00997 | 66 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.55325 | 72 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.82879 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.06026 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.56227 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.31977 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.5152 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.56037 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.6962 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.20017 | 68 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.56626 | 72 |